HYPERURICEMIA PREDICTS INCREASED SYSTEMIC INFLAMMATION, DYSLIPIDEMIA, AND HEPATIC STEATOSIS INDEPENDENT OF OBESITY AND METABOLIC SYNDROME

HYPERURICEMIA PREDICTS INCREASED SYSTEMIC INFLAMMATION, DYSLIPIDEMIA, AND HEPATIC STEATOSIS INDEPENDENT OF OBESITY AND METABOLIC SYNDROME

Hepatic steatosis 1.78*(1.004-3.15) 3.20* (2.13-4.81) * Adjusted for age, gender, hypertension, fasting glucose, presence of diabetes mellitus, diabetes medications, low-density lipoprotein cholesterol, lipid medications, smoking status (current smoker or nonsmoker), and physical activity (assessed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E1776-E1776
Hauptverfasser: Keenan, Tanya, Blaha, Michael, Nasir, Khurram, Silverman, Michael, Carvalho, Jose, Tota-Maharaj, Rajesh, Concei&ccedil, &atilde, o, Raquel, Blumenthal, Roger, Santos, Raul
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Cholesterol
Internal Medicine
Metabolic syndrome
Obesity
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hepatic steatosis 1.78*(1.004-3.15) 3.20* (2.13-4.81) * Adjusted for age, gender, hypertension, fasting glucose, presence of diabetes mellitus, diabetes medications, low-density lipoprotein cholesterol, lipid medications, smoking status (current smoker or nonsmoker), and physical activity (assessed by the International Physical Activity Questionnaire as low, moderate, or high physical activity).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)61777-X